Pacific biosciences of california, inc. (PACB)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net income (loss)

-52,548

-84,134

-114,842

-110,763

-108,707

-102,562

-92,525

-89,502

-92,501

-92,189

-90,457

-85,930

-78,890

-74,375

-56,754

-37,439

-30,875

-31,696

-49,262

-60,246

-67,447

-66,160

-64,416

-75,740

-77,075

-79,293

-83,731

-85,973

-87,989

-94,465

-95,619

-102,171

-102,159

-109,388

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities
Gain from Continuation Advances

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

7,126

7,265

7,262

7,190

7,209

7,215

7,246

7,214

7,394

8,442

7,685

6,891

5,877

3,875

3,805

3,654

3,617

3,677

3,604

3,756

3,908

4,221

4,721

5,062

5,376

5,648

5,846

6,193

6,513

6,649

6,548

6,301

5,964

5,803

0

0

0

Amortization of operating lease right-of-use assets

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and financing costs

1,062

1,212

1,162

1,112

1,066

1,024

1,021

1,037

1,121

1,203

1,243

1,262

1,209

1,158

1,104

1,052

1,005

957

913

871

831

793

756

722

688

595

0

0

0

-

-

-

-

-

-

-

-

Gain on derivative

-

16

28

40

12

167

142

-25

-630

-653

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

16,052

16,401

20,054

21,117

22,252

23,153

21,021

20,864

20,650

20,352

19,798

19,937

19,965

19,562

18,753

16,884

15,166

13,840

12,812

12,026

10,928

9,943

9,488

9,207

9,429

9,905

9,908

10,125

10,264

9,705

10,442

11,043

11,467

12,384

0

0

0

Amortization (accretion) from investment premium (discount)

580

913

1,181

1,241

1,136

758

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other items

-

-

-

-

-

-

-

-

-

-

0

0

-26

-

-205

-290

-257

-114

-286

-288

-418

-507

37

82

364

352

-952

-1,169

-1,274

-1,295

-454

-78

-253

-226

0

0

0

Changes in assets and liabilities
Accounts receivable

78

6,671

3,562

4,677

-1,173

-4,838

-2,493

-2,079

-1,989

2,012

-2,864

-902

2,331

6,176

7,496

6,376

2,722

1,738

1,794

-305

1,904

660

-1,444

151

1,374

-76

3,282

733

504

-1,735

-3,902

-2,066

1,446

4,216

0

0

0

Inventory

-2,429

-3,915

-2,864

-4,143

-4,455

-3,623

1,401

6,762

11,013

8,442

3,099

3,900

4,181

6,151

7,555

6,314

2,463

2,466

1,927

2,538

5,156

1,285

1,579

-843

-2,296

60

-781

-386

-1,060

-4,761

-7,813

-6,497

1,640

11,409

0

0

0

Prepaid expenses and other assets

668

523

589

239

515

290

-979

-1,772

-4,738

-7,803

-4,135

-5,162

1,534

202

-545

16,968

13,223

17,889

15,719

107

-326

224

-134

423

98

-840

-107

-479

-236

-50

-844

-2,781

-1,537

-1,874

0

0

0

Accounts payable

-4,491

1,713

2,141

3,211

778

-2,239

-2,594

-2,057

-89

764

1,432

775

3,352

3,402

1,322

-236

-1,738

-716

127

432

2,665

3,891

2,432

2,775

916

-1,271

516

-1,457

-1,240

-1,754

-5,409

-4,971

-5,082

-4,773

0

0

0

Accrued expenses

6,843

419

6,702

3,172

904

205

-1,482

-3,403

-1,625

-3,986

-5,879

-1,991

-360

1,053

5,140

6,635

4,385

5,732

4,238

2,952

3,022

3,536

0

0

0

-

-

-

-

-

-

-

0

-

0

0

0

Deferred revenue

-1,394

-2,134

-1,058

-692

-110

-33

2,873

1,307

1,600

1,033

-231

156

914

469

-97

99

-606

708

1,328

1,677

3,037

2,686

1,991

2,065

1,067

386

-321

-1,567

-1,608

-1,674

585

3,267

1,013

2,631

0

0

0

Operating lease liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred contractual revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,134

-14,385

-14,386

-14,386

-14,386

-12,484

-10,584

-8,684

-6,784

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

1,249

-563

281

-998

-1,200

-505

-1,405

-1,732

160

880

2,838

2,814

550

1,737

397

1,192

725

-639

-1,611

-1,829

-1,067

-1,932

-439

-1,004

-1,109

-938

0

0

0

-

-

-

-

-

-

-

-

Deferred gain from Reverse Termination fee

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-1,068

-1,078

-128

850

0

0

0

Net cash provided by (used in) operating activities

22,364

-78,312

-79,117

-76,032

-72,970

-66,430

-67,645

-71,308

-69,620

-67,518

-60,219

-58,257

-64,333

-67,929

-55,742

-55,636

-44,245

-47,889

-62,532

-52,997

-59,123

-51,468

-50,685

-25,727

-28,514

-29,833

-33,482

-69,854

-77,059

-76,822

-73,371

-79,573

-86,854

-102,974

0

0

0

Cash flows from investing activities
Purchase of property and equipment

1,700

2,836

2,753

2,020

2,763

1,854

2,856

6,017

8,109

10,433

12,024

11,068

10,418

8,207

6,434

4,592

2,749

3,009

2,608

2,339

1,849

1,609

1,234

1,274

1,089

909

1,247

1,499

1,726

1,703

2,701

4,477

8,062

9,284

0

0

0

Proceeds from disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of investments

113,064

57,727

60,665

114,431

108,259

122,183

115,976

69,658

107,467

86,339

88,411

92,457

62,884

95,848

122,892

108,571

102,697

84,579

72,660

100,117

115,163

126,413

157,466

156,899

195,596

201,547

160,002

145,054

110,218

87,889

100,550

129,777

152,987

264,071

0

0

0

Sales of investments

-

-

-

-

-

2,442

5,891

5,891

5,891

7,111

7,117

13,613

21,998

23,285

19,830

14,834

6,449

8,317

0

0

0

-

-

-

-

-

-

-

-

7,896

7,896

4,856

-14,002

36,520

0

0

0

Maturities of investments

83,000

121,110

121,860

119,390

118,340

83,180

90,680

89,760

74,866

88,071

87,759

90,325

85,262

65,896

69,996

62,525

73,416

92,341

96,466

123,289

136,860

147,586

155,521

146,061

177,249

169,239

184,487

178,889

150,779

143,488

140,744

181,968

224,385

243,281

0

0

0

Net cash provided by (used in) investing activities

-30,264

62,047

59,942

2,939

7,318

-38,415

-22,222

20,005

-34,778

-1,549

-5,557

425

33,857

-14,864

-43,966

-40,264

-29,934

8,606

29,527

27,656

26,665

19,564

-3,079

-12,012

-19,336

-33,117

23,238

35,376

43,231

61,792

45,389

52,570

49,334

6,446

0

0

0

Cash flows from financing activities
Proceeds from Continuation Advances

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable principal payoff

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock from equity plans

2,057

8,548

13,888

15,225

13,855

9,652

4,277

5,200

7,993

8,914

9,018

9,458

7,714

7,729

9,427

8,881

8,352

7,363

6,114

4,261

4,091

3,968

3,667

4,487

4,155

3,079

2,733

1,968

2,185

2,705

2,960

6,112

9,165

7,743

0

0

0

Proceeds from issuance of debt agreement, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,766

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

38,057

26,548

13,696

79,893

78,399

107,182

101,999

37,883

100,874

68,809

68,913

69,532

39,378

65,929

95,294

94,748

63,988

36,463

24,802

23,071

21,468

41,991

24,408

25,106

36,073

42,772

42,453

41,688

30,606

2,705

2,960

6,112

9,165

7,743

0

0

0

Net increase in cash and cash equivalents and restricted cash

30,157

10,283

-5,479

6,800

12,747

2,337

12,132

-13,420

-3,524

-258

3,137

11,700

8,902

-16,864

-4,414

-1,152

-10,191

-2,820

-8,203

-2,270

-10,990

10,087

-29,356

-12,633

-11,777

-20,178

32,209

7,210

-3,222

-12,325

-25,022

-20,891

-28,355

-88,785

0

0

0

Supplemental disclosure of non-cash investing and financing activities
Inventory transferred to property and equipment

-

-

-

-

-

-

-

-

-

1,267

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Changes in unpaid property and equipment

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment paid for by landlord

-

-

-

-

-

-

-

-

-

12,600

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in deposits for property and equipment paid in prior period

-

-

-

-

-

-

-

-

-

9,694

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Vesting of stock options related to early exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

At the Market Offering [Member]
Proceeds from issuance of common stock from offering, net of issuance costs

-

-

-

-

-

-

0

0

0

-

-

-

-

58,200

0

0

0

-

-

-

-

38,023

20,741

20,619

31,918

19,927

0

0

0

-

-

-

-

-

-

-

-